Aurinia Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Aurinia Pharmaceuticals Inc. (AUPH) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.080.050.090.230.270.310.13
Short-Term Investments0.280.300.300.230.130.000.00
Cash & Short-Term Investments0.360.350.390.470.400.310.13
Accounts Receivable0.040.020.010.020.000.000.00
Inventory0.040.040.020.020.010.000.00
Other Current Assets0.000.000.000.010.010.000.00
Total Current Assets0.450.420.440.510.420.320.13
Non-Current Assets
Property, Plant & Equipment (Net)0.100.120.010.010.010.000.00
Long-Term Investments0.000.000.000.000.020.000.00
Intangible Assets0.000.000.010.010.010.000.00
Other Non-Current Assets0.000.000.010.010.000.000.00
Total Non-Current Assets0.100.120.030.030.040.010.01
Total Assets0.550.550.470.540.460.320.15
Current Liabilities
Accounts Payable0.010.000.000.000.000.010.01
Short-Term Debt0.020.000.000.000.000.000.00
Accrued Liabilities0.060.050.040.030.020.000.00
Deferred Revenue0.010.000.000.000.000.000.00
Other Current Liabilities0.000.000.000.000.010.000.00
Total Current Liabilities0.100.080.050.040.030.010.01
Non-Current Liabilities
Long-Term Debt0.060.080.010.010.010.000.00
Other Non-Current Liabilities0.010.000.010.020.020.010.00
Total Non-Current Liabilities0.080.090.020.020.020.010.03
Total Liabilities0.170.170.070.060.060.030.03
Stockholders' Equity
Common Stock1.191.201.191.180.940.000.00
Retained Earnings-0.94-0.94-0.86-0.76-0.58-0.47-0.42
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital0.130.120.090.060.040.030.02
Shares Outstanding0.140.140.140.140.000.000.00
Total Stockholders' Equity0.380.380.410.480.410.300.11
Total Liabilities & Equity0.550.550.470.540.460.320.15